(Q33360753)

26 July 2017

title

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations (English)

1 reference

Adaptive radiation therapy

26 July 2017

main subject

0 references

0 references

1 reference

Dominique Figarella-Branger

5

object named as

Dominique Figarella-Branger

0 references

Olivier Chinot

1 reference

ORCID Public Data File 2021

author name string

Olivier-L Chinot

1

1 reference

26 July 2017

Maryline Barrie

2

1 reference

26 July 2017

Elisabeth Frauger

3

1 reference

26 July 2017

Henry Dufour

4

1 reference

26 July 2017

Jacky Palmari

6

1 reference

26 July 2017

D Braguer

7

1 reference

26 July 2017

Khe Hoang-Xuan

8

1 reference

26 July 2017

Karima Moktari

9

1 reference

26 July 2017

Jean-Claude C Peragut

10

1 reference

26 July 2017

Pierre-Marie M Martin

11

1 reference

26 July 2017

François Grisoli

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

100

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

2208-2214

1 reference

Malignant supratentorial glioma in the elderly: is radiotherapy useful?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

Age influences chemotherapy response in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Descriptive epidemiology of cerebral gliomas in France.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Efficacy of radiotherapy for malignant gliomas in elderly patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Treatment of malignant gliomas in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

A prospective study on glioblastoma in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

An Australian experience with temozolomide for the treatment of recurrent high grade gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20224

7 January 2021

Identifiers

DOI

10.1002/CNCR.20224

1 reference

26 July 2017

1 reference